Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_assertion description "[KD of SLC25A43 also reduced the inhibitory effect of trastuzumab on cell proliferation in the HER2-positive cancer cell line BT-474 (P<0.05), and the drug-induced G0/G1�block (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_assertion evidence source_evidence_literature NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_assertion SIO_000772 23354756 NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_assertion wasDerivedFrom befree-20150227 NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_assertion wasGeneratedBy ECO_0000203 NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP980046.RADYy3AfZe_NI6_b7xjSCtA4IreKf90en1Y57DqPByYiE130_provenance.